awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40812061-C82E2B78-629F-4B12-98C4-943A7434BFC4
Q40812061-C82E2B78-629F-4B12-98C4-943A7434BFC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40812061-C82E2B78-629F-4B12-98C4-943A7434BFC4
Advances in anti-IgE therapy
P2860
Q40812061-C82E2B78-629F-4B12-98C4-943A7434BFC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40812061-C82E2B78-629F-4B12-98C4-943A7434BFC4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c6463520d1a7b16314bb7551252b45cffcc39cf
P2860
D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment.